120 Capital
Overview
120 Capital is a US-domiciled global healthcare and life science venture capital fund with offices in Boston, Palo Alto, Hong Kong, and Shanghai. It is the successor fund to 6 Dimensions Capital and invests in healthcare companies across the US, Europe, China, and Israel.
Portfolio Companies
2
Website
120capm.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| VFLO Medical | Dec 2024 | Series B | Co-investor |
| Immunitas Therapeutics | Aug 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is 120 Capital based?
120 Capital is headquartered in Boston, Massachusetts, United States.
When was 120 Capital founded?
Founding year information for 120 Capital is not publicly available.
How many portfolio companies does 120 Capital have?
120 Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in 120 Capital's portfolio?
Portfolio companies visible on Caplight include VFLO Medical, Immunitas Therapeutics.
What was 120 Capital's most recent investment shown here?
120 Capital's most recent investment in this portfolio sample was in VFLO Medical in 2024.
What sectors does 120 Capital focus on?
120 Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does 120 Capital focus on?
120 Capital typically invests at the Mid stage.
What is 120 Capital's AUM?
120 Capital's assets under management are estimated between $2.0B and $2.0B.